Stockpile Inventory Modernization Act of 2020

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 6517 Introduced in House (IH)]

<DOC>






116th CONGRESS
  2d Session
                                H. R. 6517

To amend the Public Health Service Act to authorize the transfer to any 
   Federal department or agency, on a reimbursable basis, any drugs, 
  vaccines and other biological products, medical devices, and other 
 supplies in the Strategic National Stockpile, and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             April 17, 2020

   Mrs. Brooks of Indiana (for herself and Ms. Eshoo) introduced the 
   following bill; which was referred to the Committee on Energy and 
                                Commerce

_______________________________________________________________________

                                 A BILL


 
To amend the Public Health Service Act to authorize the transfer to any 
   Federal department or agency, on a reimbursable basis, any drugs, 
  vaccines and other biological products, medical devices, and other 
 supplies in the Strategic National Stockpile, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Stockpile Inventory Modernization 
Act of 2020''.

SEC. 2. REIMBURSABLE TRANSFERS FROM STRATEGIC NATIONAL STOCKPILE.

    Section 319F-2(a) of the Public Health Service Act (42 U.S.C. 247d-
6b(a)) is amended by adding at the end the following:
            ``(6) Transfers and reimbursements.--
                    ``(A) In general.--Without regard to chapter 5 of 
                title 40, United States Code, the Secretary may 
                transfer to any Federal department or agency, on a 
                reimbursable basis, any drugs, vaccines and other 
                biological products, medical devices, and other 
                supplies in the stockpile if--
                            ``(i) the transferred supplies are less 
                        than six months from expiry;
                            ``(ii) the stockpile is able to replenish 
                        the supplies, as appropriate; and
                            ``(iii) the Secretary decides the transfer 
                        is in the best interest of the United States 
                        Government.
                    ``(B) Use of reimbursement.--Reimbursement derived 
                from the transfer of supplies pursuant to subparagraph 
                (A) may be used by the Secretary, without further 
                appropriation and without fiscal year limitation, to 
                carry out this section.
                    ``(C) Report.--Not later than September 30, 2022, 
                the Secretary shall submit to the Committee on Energy 
                and Commerce of the House of Representatives and the 
                Committee on Health, Education, Labor, and Pensions of 
                the Senate a report on each transfer made under this 
                paragraph and the amount received by the Secretary in 
                exchange for that transfer.
                    ``(D) Sunset.--The authority to make transfers 
                under this paragraph shall cease to be effective on 
                September 30, 2023.''.
                                 <all>